Image alt

International Corporates and Institutional investors

We are the BNP Paribas broker dedicated to mid & small caps

Our services

  • Equity Sales

    01

    Equity sales

    The Institutional Equity Sales team Is comprised of former Equity analysts, PMs and structurers, a combination of Individuals that offers a deep expertise on French small and midcap combining research-driven investment ideas with market momentum

    Read more
  • Immeuble

    02

    Equity Research

    Our analysts cover more than 120 smidcaps stocks, mostly listed In Paris, with a main focus on Innovative sectors (new energy, greentech, digital, biotech, etc.) but also some value stories.

    Read more
  • Immeuble

    03

    Equity Capital Markets

    With a sizable market share of the French ECM market, we regularly offer our clients primary and secondary deals ranging from a few millions up to 200 million euros per transaction.

    Read more
  • immeuble

    04

    Corporate Access

    Every year, we organize In H1 the Portzamparc Conference (80+ corporates over 2 days in Paris) as well as three thematic seminars In H2 (Biotech/Healthcare, Impact Investing, Tech). All year long, we arrange one-to-one and one-to-few meetings, either In Paris or virtually. We can also arrange reverse roadshows and site visits across France.

    Read more

Who are we ?

Portzamparc is BNPP's fully owned subsidiary dedicated to French Small and Midcaps with a comprehensive approach on this market.  ECM
Portzamparc is one of the most experienced team for French Midcap

SALES and TRADING 

  • The Equity Sales Teams sits within the Trading and Execution team offering research-driven investment ideas and liquidity.

EQUITY RESEARCH 

Portzamparc offers one of the largest teams in France on French Small and midcaps:

  • 10 analysts covering 130 stocks
  • 360° approach combining fundamental research with an "in-house" ESG scoring

EQUITY CAPITAL MARKET

with a track record that speaks for Itself:

  •  Around 20 operations per year (IPO, ABBs and right issues)
  • up to €150M deals with a focus on innovative companies
  • A wide distribution capacity

CORPORATE ACCESS

  • Several events throughout the year:  DIGITAL, BIOTECH & HEALTH, IMPACT INVESTING, etc.. and our key SMALL AND MIDCAP event (2days, over 130 Issuers)
  • Several Investment Lunches, roadshows and tailored reverse roadshows

 

More about us